Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer

Radioiodine ablation following surgery is the accepted treatment for patients with differentiated thyroid cancer (DTC). Since that surgical volume and radioiodine dose can have impact on treatment outcome, we aimed to evaluate them on the treatment outcome of low-risk DTC patients. Low-risk DTC pati...

Full description

Bibliographic Details
Main Authors: Ghazal Norouzi, Babak Shafiei, Farzad Hadaegh, Mohsen Qutbi, Isa Neshandar Asli, Esmail Jafari, Hamid Javadi, Majid Assadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2021;volume=20;issue=1;spage=17;epage=22;aulast=